News & Events

December 2014

Share: Share Using Facebook  Share Using Twitter
CDI Notebook
bogo_padded

DECEMBER 2014

Welcome to our monthly enewsletter, CDI Notebook, focused on keeping you abreast of the latest innovations using CDI’s iCell® and MyCell® products.

In this issue:
Trending
Webinars
Publications
Applications
Presentations/Posters

horizontal rule

Trending

CIPA Workshop

CIPA Workshop (Dec 11 | Silver Spring, MD). Register now for the workshop, Rechanneling the Current Cardiac Paradigm: Arrhythmia Risk Assessment during Drug Development without the Thorough QT Study, and join the conversation on the latest progress in the CIPA initiative.

Register>>

horizontal rule

Webinars

“First in Human” – The Potential of Neural Stem Cell-based Approaches for Treatment of Brain Disorders (Dec 16 | Hosted by Cell Press). Sign up today to hear how pluripotent stem cell technologies can model “human” neural disease pathology and serve as platforms for drug development. Presenters: Dr. Ricardo Dolmetsch, Stanford University; Dr. Kevin Eggan, Harvard University; Dr. Fred H. Gage, Salk Institute

Register>>

horizontal rule

Publications

Enhancing the Functional Maturity of iPSC-derived Human Hepatocytes via Controlled Presentation of Cell-Cell Interactions In Vitro. Discover how an engineered co-culture platform increased the maturation and longevity of iCell Hepatocytes when benchmarked against primary human hepatocytes. iCell Hepatocytes demonstrated increased maturity via global gene expression profiles, hepatic polarity, secretion of albumin and urea, basal CYP450 activities, phase-II conjugation, drug-mediated CYP450 induction, and drug-induced hepatotoxicity further enhancing their utility in compound screening.

Berger DR, Ware BR, et al. (2014) Hepatology.

Article>>

Human Induced Pluripotent Stem Cell-derived Hepatocytes for Toxicology Testing. Read how combining iCell Hepatocytes with organotypic culture systems enables researchers to maximize the potential of these technologies. iCell Hepatocytes benefit from the complex culture conditions while providing stability and reproducibility to the use of organotypic cultures in drug research.

Mann DA (2014) Expert Opin Drug Metab Toxicol.

Article>>

Human Stem Cell-derived Cardiomyocytes in Cellular Impedance Assays: Bringing Cardiotoxicity Screening to the Front Line. Read this review for an update on measuring cellular impedance and how it may be applied to detect multiple toxicity modalities and implemented into a cascading screening paradigm to detect cardiotoxicity.

Peters M, Lamore SD, et al. (2014) Cardiovasc Toxicol.

Article>>

A Multi-parameter In Vitro Screen in Human Stem Cell-derived Cardiomyocytes Identifies Ponatinib-induced Structural and Functional Cardiac Toxicity. Find out how scientists moved beyond single end-point assays and combined a suite of biochemical, structural, and functional assays to identify and characterize the cardiotoxicity caused by ponatinib, a multi-targeted tyrosine-kinase and pan-ABL inhibitor.

Talbert DR, Doherty KR, et al. (2014) Tox Sci.

Article>>

Optimization and Critical Evaluation of Decellularization Strategies to Develop Renal Extracellular Matrix Scaffolds as Biological Templates for Organ Engineering and Transplantation. Learn how researchers utilized iCell Endothelial Cells in biomatrices and decellularized organ scaffolds that may ultimately serve as a model for kidney bioengineering.

Caralt M, Uzarski JS, et al. (2014) Am J Transplant.

Article>>

horizontal rule

Applications

application

Inducing Hypoxia and Screening for Cardioprotection. Learn how to induce hypoxia in iCell Cardiomyocytes, interrogate the cellular responses, and screen for cardioprotective compounds.

Details>>

horizontal rule

Presentations/Posters

Check out the following presentation and posters, presented at recent meetings, now accessible online:

    • iPSC-derived Cellular Components in Organotypic Systems for Toxicity Assessment (FAST Congress)

Presentation>>

presentation

    • Characterization of an Isogenic Disease Model of Alzheimer’s Disease from Human iPS Cell-derived Neurons (Society for Neuroscience Meeting | “Hot Topics” awardee)

Poster>>

    • Development and Characterization of Scalable Human Induced Pluripotent Stem Cell-derived Midbrain Dopaminergic Neurons for Drug Discovery and Disease Modeling (Society for Neuroscience Meeting)

Poster>>

    • Human Neural Microtissues Derived from Induced Pluripotent Stem Cells for Toxicity Testing (Society for Neuroscience Meeting)

Poster>>

    • A New MEA Analysis Tool for Measuring Pharmaco-influences on Human iPS Cell-derived Neurons (Society for Neuroscience Meeting)

Poster>>

horizontal rule
© 2014 Cellular Dynamics International, Inc.
525 Science Drive, Madison, WI 53711
+1 (608) 310-5100 or toll-free (877) 310-6688
www.cellulardynamics.com
Follow us: CDI on Facebook CDI on LinkedIn CDI on Twitter CDI on YouTube